-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Adefovir Diphosphate-[d4] Triethylamine Salt
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1346604-40-7.gif)
| Category | Hepatitis B Virus (HBV) |
| CAS | 1346604-40-7 |
| Description | Adefovir Diphosphate-[d4] Triethylamine Salt is the labelled salt of Adefovir Diphosphate, which is a metabolite of Adefovir. |
Product Information
| Synonyms | Adefovir-d4 Diphosphate Triethylamine Salt; Diphosphoric Acid Anhydride P-[[2-(6-Amino-9H-purin-9-yl)ethoxy-d4]-methyl] phosphonic Acid; PMEApp-d4 Triethylamine Salt; PMEA-DP-d4 Triethylamine Salt; 9-(2-(Phosphonomethoxy)ethyl)adenine diphosphate-d4 Triethylamine Salt; N-(2-Diphosphorylphosphonylmethoxyethyl)-adenine-d4 Triethylamine Salt |
| IUPAC Name | [2-(6-aminopurin-9-yl)-1,1,2,2-tetradeuterioethoxy]methyl-[hydroxy(phosphonooxy)phosphoryl]oxyphosphinic acid;N,N-diethylethanamine |
| Molecular Weight | 437.17 (free acid) |
| Molecular Formula | C8H10D4N5O10P3.x(C6H15N) |
| Canonical SMILES | CCN(CC)CC.C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)OP(=O)(O)OP(=O)(O)O)N |
| InChI | InChI=1S/C8H14N5O10P3.C6H15N/c9-7-6-8(11-3-10-7)13(4-12-6)1-2-21-5-24(14,15)22-26(19,20)23-25(16,17)18;1-4-7(5-2)6-3/h3-4H,1-2,5H2,(H,14,15)(H,19,20)(H2,9,10,11)(H2,16,17,18);4-6H2,1-3H3/i1D2,2D2; |
| InChIKey | CMMZUURGSBCDLQ-PBCJVBLFSA-N |
| Purity | ≥98% |
| Solubility | 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| Target | HBV; Reverse Transcriptase |
